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FOXO induces a whole suite of genes, including thoseTipping the Balance
involved in gluconeogenesis (PEPCK), detoxification oftoward Longevity reactive oxygen species (MnSOD), heat shock, DNA
damage repair (GADD45), growth control (4EBP), cell
cycle arrest (p27KIP), cell death (BIM, FAS ligand), and
Genetic experiments in C. elegans suggested that SIR2, innate immunity (see references within Motta et al.,
an NAD-dependent protein deacetylase, acts through 2004). Of all the traits controlled by FOXO, stress resis-
FOXO/DAF-16 transcription factor to prolong life. Re- tance is most tightly correlated with longevity. How then
cent studies show that mammalian SIR2 deacetylates might moderation and specificity be achieved?
FOXO, and may maximize survival by tempering cell Here SIR2 may provide some answers. SIR2 was origi-
death and increasing stress resistance. nally discovered in yeast as an NAD-dependent histone
deacetylase with a role in silencing at the rDNA, telo-
The provocative finding that single gene mutations can meres, and mating type loci (Hekimi and Guarente,
dramatically extend life span in several model organisms 2003). Notably, increased SIR2 dose prolongs yeast rep-
reveals that aging is plastic, regulated, and under ge- licative life span by about 40%, while loss of function
netic control. At least two pivotal regulators conserved abrogates extended survival brought about by glucose
across taxa robustly extend organismal survival, fork- limitation, a model of caloric restriction. Caloric restric-
head transcription factor FOXO, and the SIR2 (silencing tion prolongs life span in numerous species, and it is
information regulator 2) protein deacetylase. proposed that SIR2 couples metabolic signals to down-
FOXO mediates the transcriptional output of insulin/
stream regulatory events.
IGF-1 signal transduction, which regulates the longevity
Resounding evidence that SIR2 regulates animal life
of species as diverse as worms, flies, and mice (reviewed
span came from studies in the worm, where extra dosesin Tatar et al., 2003). Insulin/IGF-1 signaling is pro-aging,
of sir-2.1 (one of four sirtuin homologs) extend adult lifewhile mild inhibition of the pathway prolongs life. When
by 50% (Tissenbaum and Guarente, 2001). Moreover,insulin/IGF-1 signaling is active, a PI3 kinase/AKT kinase
extension was dependent on FOXO/daf-16, bringingcascade phosphorylates FOXO, leading to its nuclear
these pivotal regulators together in a single pathway.exclusion. When insulin signaling is inhibited, unphos-
But the specific nature of this interaction was unknown.phorylated FOXO enters the nucleus where it promotes
Recently, several reports (Brunet et al., 2004; Mottaprograms of somatic endurance, stress resistance, and
et al., 2004) have explored the physical and biochemicallongevity.
interaction of mammalian FOXO homologs with SIRT1,But how should blunted insulin/IGF-1 signaling pro-
the closest SIR2 homolog among the seven mammalianmote longevity when normally it is associated with frank
sirtuins. Indeed, consistent with unified action, it wasdiabetes and premature senescence? One key is moder-
shown that SIRT1 and FOXO physically interacted ination: a modest downregulation of the pathway leads
coimmunoprecipitation experiments. Moreover, in re-to healthy old age, while strong downregulation leads
sponse to stress FOXO was a substrate for acetylationto frailty and morbidity. The other key is specificity. While
by protein acetylases p300 and PCAF and subsequentinsulin/IGF-I signaling is traditionally known for its role
deacetylation by SIRT1 and other deacetylases (Brunetin metabolic and growth control, it may be a general
sensor for all kinds of environmental stress. In turn, et al., 2004; Motta et al., 2004).
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Deacetylation of transcriptional complexes is gener- but early onset of age-related decline and a shortened
life (Tyner et al., 2002). Excessive cell death, depletionally associated with diminished transcriptional activa-
tion. Consistent with this, FOXO proapoptotic target genes, of stem cell niches, and cellular senescence may con-
tribute to shortevity. Clearly, understanding how FOXO,BIM and FAS ligand, were downregulated by SIRT1 (Bru-
net et al., 2004; Motta et al., 2004). Correlatively, apopto- SIRT1, and p53 functionally interact will be important to
unraveling this puzzle. Tantalizingly, p53 and FOXO weresis in various cell types was mitigated by greater SIRT1
activity and enhanced by SIRT1 loss of function. Simi- shown to coimmunoprecipitate in response to oxidative
stress (Brunet et al., 2004).larly, SIRT1 dampened transcriptional activation from
IGFBP1 and PEPCK promoters in vivo and coassembled These exciting findings raise numerous questions.
Foremost among them is how will SIRT1 and FOXOwith FOXO at the IGFBP1 promoter as shown by chro-
matin immunoprecipitation experiments (Motta et al., activity affect mammalian stress response and longevity
in vivo, and what is their relationship to caloric restric-2004).
How acetylation state influences FOXO activity is not tion? Because these regulators have various roles,
stage- and tissue-specific genetic manipulations arequite so simple, however, and is apparently promoter
specific. For example, SIRT1 increased transcription likely required. Second, how is specificity determined?
FOXO could respond to various signals as growth factorfrom the FOXO target, GADD45, suggesting that SIRT1
augments DNA repair (Brunet et al., 2004). Accordingly, deprivation and oxidative stress through insulin/IGF sig-
naling or other inputs. SIRT1 activity could reflect theSIRT1 conferred resistance to etoposide (Brunet et al.,
2004), a DNA damaging agent, while thymocytes derived internal metabolic state of the cell, or could itself re-
spond to distinct signals, since its activity is modulatedfrom SIRT1 knockout mice were more sensitive to ioniz-
ing radiation (Cheng et al., 2003). by polyphenolics (Howitz et al., 2003). Aside from the
While it is yet unknown whether SIRT1 and FOXO are issues of promoter and tissue specificity, FOXO may
indeed positive effectors of mammalian longevity, the have a complex regulatory code, as five acetylated and
emergent hypothesis is that SIRT1 may specifically eight phosphorylated residues were modified in re-
modulate FOXO activity toward maximal survival. Atten- sponse to stress (Brunet et al., 2004). Cracking this code
uating FOXO in some contexts may be advantageous, may also help illuminate the specification of longer life.
since overactivity could foment excessive cell death and
organ decline, or lead to devastating metabolic disor- Adam Antebi
ders. Moreover, in quiescent or differentiated cells,
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where FOXO may be less susceptible to regulation by
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growth factor signaling, deacetylation might be an im-
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portant mechanism to dampen the response.
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